Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opsens Inc V.OPS


Primary Symbol: T.OPS

OpSens Inc. is a medical device cardiology-focused company. The Company offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. The Company’s segments include Medical and Industrial. The Medical segment focuses on physiological measurements, such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and also supplies a range of miniature optical sensors to measure pressure and temperature to be used in a range of applications that can be integrated into other medical devices. The Industrial segment develops, manufactures and installs fiber optic sensing solutions for critical and demanding industrial applications. Its flagship product, the OptoWire, is a second-generation fiber optic pressure guidewire designed to provide the lowest drift in the industry and lesions access. It is approved for sale in the United States, European Union, Japan and Canada.


TSX:OPS - Post by User

<< Previous
Bullboard Posts
Next >>
Post by Nadia6519on Jan 09, 2022 10:50am
215 Views
Post# 34297459

La Presse de ce matin...

La Presse de ce matin...

Une entreprise de Qubec spcialise dans les technologies mdicales est apparue cette semaine sur au moins deux courtes listes des meilleures ides de placement pour commencer 2022.

RBC Marchs des capitaux a d’abord rvl mercredi l’ajout d’Opsens  sa liste des 24 titres de petites capitalisations acheter.

Les experts de RBC voient une « opportunit significative » pour le fil-guide d’Opsens pouvant livrer une prothse valvulaire aortique tout en mesurant en continu la pression pendant l’intervention visant le remplacement d’une valve aortique. RBC croit que le produit d’Opsens peut tablir un « nouveau standard » mdical.

 

La firme torontoise M Partners a de son ct rvl en milieu de semaine qu’Opsens tait l’une de ses sept suggestions d’investissement pour 2022 et le seul titre qubcois sur sa liste. La firme s’attend ce qu’Opsens poursuive son dveloppement et sa croissance au cours de la prochaine anne.

<< Previous
Bullboard Posts
Next >>